The earnings call reflects a strong performance for Nephros, highlighted by substantial revenue growth, sustained profitability, and strategic innovation in new markets. Despite challenges with increased operating expenses and tariff impacts, the company's robust cash flow and expanding customer base indicate a positive outlook.

Company Guidance

During Nephros, Inc.'s third quarter 2025 conference call, the company reported $4.8 million in revenue, marking a 35% increase over the same period in 2024, and celebrated their fifth consecutive quarter of profitability. They highlighted a gross margin of 61%, consistent with the prior year, despite increased inventory handling expenses. Net income rose significantly to $337,000 from $183,000 a year earlier, while adjusted EBITDA improved to $418,000. The company also noted a strategic focus on expanding into new markets, such as municipalities and labs, with innovations like their PFAS removal solution. Year-to-date results showed a 37% revenue increase to $14.1 million, with gross margins improving to 63%. Nephros maintained a debt-free status with a cash balance of $5.2 million as of September 30, 2025, up from $3.8 million at the end of 2024.

Significant Revenue Growth

Nephros reported third quarter net revenue of $4.8 million, representing a 35% increase over the corresponding period in 2024.

Sustained Profitability

The company marked its fifth consecutive quarter of profitability with a net income of $337,000, compared to $183,000 in the same period last year.

Expanded Customer Base

Active customer sites grew to over 1,650 as of September 30, 2025, indicating strong customer retention and expansion.

Innovation in PFAS Filtration

The launch of the PFAS removal solution opens new markets beyond traditional patient care, potentially driving future growth.

Improved Cash Flow

Net cash provided by operating activities was $99,000 in Q3 2025, a significant improvement from net cash used of $623,000 in the prior year period.

Nephros (NEPH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

NEPH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 05, 2026	2025 (Q4)	<0.01 / -	0.03	―	―	―
Nov 06, 2025	2025 (Q3)	-0.02 / 0.03	0.02	50.00% (<+0.01)	―
Aug 07, 2025	2025 (Q2)	-0.03 / 0.02	-0.03	166.67% (+0.05)	―
May 08, 2025	2025 (Q1)	>-0.01 / 0.05	-0.02	350.00% (+0.07)	―	―
Mar 06, 2025	2024 (Q4)	0.03 / 0.03	-0.06	150.00% (+0.09)	―
Nov 07, 2024	2024 (Q3)	-0.02 / 0.02	-0.02	200.00% (+0.04)	―
Aug 08, 2024	2024 (Q2)	-0.01 / -0.03	-0.04	25.00% (+0.01)	―
May 09, 2024	2024 (Q1)	-0.04 / -0.02	-0.03	33.33% (<+0.01)	―
Mar 07, 2024	2023 (Q4)	-0.03 / -0.06	-0.07	14.29% (+0.01)	―
Nov 08, 2023	2023 (Q3)	-0.07 / -0.02	-0.31	93.55% (+0.29)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

NEPH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 06, 2025	$5.20	$4.60	-11.54%
Aug 07, 2025	$2.89	$3.90	+34.95%
May 08, 2025	$1.99	$1.90	-4.52%
Mar 06, 2025	$1.43	$1.65	+15.38%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Nephros Inc (NEPH) report earnings?

Nephros Inc (NEPH) is schdueled to report earning on Mar 05, 2026, TBA (Confirmed).

What is Nephros Inc (NEPH) earnings time?

Nephros Inc (NEPH) earnings time is at Mar 05, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is NEPH EPS forecast?

NEPH EPS forecast for the fiscal quarter 2025 (Q4) is <0.01.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing